A MicroRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapy

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Bi, Nan ^a   Cao, Jianzhong ^a   Song, Yongmei ^a   Shen, Jie ^a   Liu, Wenyang ^a   Fan, Jing ^a   He, Jie ^a   Shi, Yuankai ^a   Zhang, Xun ^a   Lu, Ning ^a   Zhan, Qimin ^a   Wang, Luhua ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; MICRORNA; MICRORNA 150; MICRORNA 886 3P; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SMOKING; ADJUVANT CHEMOTHERAPY; FOLLOW UP; GENETICS; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; SMALL CELL LUNG CARCINOMA;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SMALL CELL LUNG CARCINOMA; TRANSCRIPTOME;

EID: 84898646407     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091388     Document Type: Article

References (45)

1. Crivellari G, Monfardini S, Stragliotto S, Marino D, Aversa SM (2007) Increasing chemotherapy in small-cell lung cancer: from dose intensity and density to megadoses. The oncologist 12: 79-89. (Pubitemid 46143505)
2. Salgia R, Skarin AT (1998) Molecular abnormalities in lung cancer. J Clin Oncol 16: 1207-1217. (Pubitemid 28108759)
3. Wistuba, II, Gazdar AF, Minna JD (2001) Molecular genetics of small cell lung carcinoma. Seminars in oncology 28: 3-13. (Pubitemid 32730372)
4. Shiao TH, Chang YL, Yu CJ, Chang YC, Hsu YC, et al. (2011) Epidermal growth factor receptor mutations in small cell lung cancer: a brief report. J Thorac Oncol 6: 195-198.
5. Zhao L, Wang L, Ji W, Wang X, Zhu X, et al. (2009) Elevation of plasma TGFbeta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. International journal of radiation oncology, biology, physics 74: 1385-1390.
6. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, et al. (2008) Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer research 68: 26-33. (Pubitemid 351380102)
7. Kim H, Huang W, Jiang X, Pennicooke B, Park PJ, et al. (2010) Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proceedings of the National Academy of Sciences of the United States of America 107: 2183-2188.
8. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer research 67: 8699-8707. (Pubitemid 47437445)
9. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
10. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England journal of medicine 353: 1793-1801. (Pubitemid 41549891)
11. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer research 64: 3753-3756. (Pubitemid 38697282)
12. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, et al. (2009) Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. The Journal of biological chemistry 284: 5731-5741.
13. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, et al. (2008) Downregulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. The Journal of biological chemistry 283: 33394-33405.
14. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America 103: 2257-2261. (Pubitemid 43271657)
15. Hurteau GJ, Carlson JA, Spivack SD, Brock GJ (2007) Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer research 67: 7972-7976. (Pubitemid 47395127)
16. Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, et al. (2008) MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 27: 3845-3855. (Pubitemid 351862062)
17. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, et al. (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer research 65: 9628-9632. (Pubitemid 41541436)
18. Eder M, Scherr M (2005) MicroRNA and lung cancer. The New England journal of medicine 352: 2446-2448. (Pubitemid 40958446)
19. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, et al. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 16: 610-619.
20. Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, et al. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 39 untranslated region increases non-small cell lung cancer risk. Cancer research 68: 8535-8540.
21. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer cell 13: 48-57.
22. Watanabe T, Takeda A, Mise K, Okuno T, Suzuki T, et al. (2005) Stage-specific expression of microRNAs during Xenopus development. FEBS letters 579: 318-324. (Pubitemid 40092406)
23. Cao J, Song Y, Bi N, Shen J, Liu W, et al. (2013) DNA methylation mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer. Cancer research.
24. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, et al. (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. The New England journal of medicine 350: 1828-1837. (Pubitemid 38917249)
25. Liu N, Chen NY, Cui RX, Li WF, Li Y, et al. (2012) Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol 13: 633-641.
26. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, et al. (2005) Real-Time quantification of microRNAs by stem-loop RT-PCR. Nucleic acids research 33: e179.
27. Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13: 358-369.
28. Lee HW, Lee EH, Ha SY, Lee CH, Chang HK, et al. (2012) Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors. Pathol Int 62: 583-591.
29. Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, et al. (2008) Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-Time RTPCR. Clin Chem 54: 1696-1704.
30. Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, et al. (2009) Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 27: 2030-2037.
31. Lee JH, Voortman J, Dingemans AM, Voeller DM, Pham T, et al. (2011) MicroRNA expression and clinical outcome of small cell lung cancer. PloS one 6: e21300.
32. Ranade AR, Cherba D, Sridhar S, Richardson P, Webb C, et al. (2010) MicroRNA 92a-2.*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J Thorac Oncol 5: 1273-1278.
33. Simon G, Ginsberg RJ, Ruckdeschel JC (2001) Small-cell lung cancer. Chest Surg Clin N Am 11: 165-188, ix. (Pubitemid 32215730)
34. Zhu H, Zhou Z, Wang Y, Bi N, Feng Q, et al. (2011) Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis. Cancer 117: 5423-5431.
35. Srivastava SK, Bhardwaj A, Singh S, Arora S, Wang B, et al. (2011) MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis 32: 1832-1839.
36. Zhang J, Luo N, Luo Y, Peng Z, Zhang T, et al. (2012) microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int J Oncol 40: 747-756.
37. Ma Y, Zhang P, Wang F, Zhang H, Yang J, et al. (2012) miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Gut 61: 1447-1453.
38. Li YJ, Zhang YX, Wang PY, Chi YL, Zhang C, et al. (2012) Regression of A549 lung cancer tumors by anti-miR-150 vector. Oncol Rep 27: 129-134.
39. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, et al. (2011) The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 25: 1324-1334.
40. Jiang X, Huang H, Li Z, Li Y, Wang X, et al. (2012) Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-Associated leukemia. Cancer cell 22: 524-535.
41. Cook RM, Miller YE, Bunn PA Jr (1993) Small cell lung cancer: etiology, biology, clinical features, staging, and treatment. Curr Probl Cancer 17: 69-141.
42. Ignatius Ou SH, Zell JA (2009) The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition. J Thorac Oncol 4: 300-310.
43. Treppendahl MB, Qiu X, Sogaard A, Yang X, Nandrup-Bus C, et al. (2012) Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML. Blood 119: 206-216.
44. Xiong Y, Zhang L, Holloway AK, Wu X, Su L, et al. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. PloS one 6: e24717.
45. Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, et al. (2013) Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 14: 589.